Global Major Depressive Disorder Market Size, Status and Forecast 2020-2026

Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.
In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.
Market Analysis and Insights: Global Major Depressive Disorder Market
In 2019, the global Major Depressive Disorder market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Major Depressive Disorder Scope and Market Size
Major Depressive Disorder market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Major Depressive Disorder market is segmented into Drugs Therapy, Biological Therapy, Meditation, Physiotherapy, Other, etc.
Segment by Application, the Major Depressive Disorder market is segmented into Under 25 Years Old, 25-45 Years Old, Above 45 Years Old, etc.
Regional and Country-level Analysis
The Major Depressive Disorder market is analysed and market size information is provided by regions (countries).
The key regions covered in the Major Depressive Disorder market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Major Depressive Disorder Market Share Analysis
Major Depressive Disorder market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Major Depressive Disorder business, the date to enter into the Major Depressive Disorder market, Major Depressive Disorder product introduction, recent developments, etc.
The major vendors include Pfizer, Eli Lilly, H. Lundbeck, Otsuka Pharmaceutical, AstraZeneca, Alkermes, Takeda Pharmaceutical, Naurex, Euthymics Bioscience, E-therapeutics, etc.

This report focuses on the global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Pfizer
Eli Lilly
H. Lundbeck
Otsuka Pharmaceutical
AstraZeneca
Alkermes
Takeda Pharmaceutical
Naurex
Euthymics Bioscience
E-therapeutics

Market segment by Type, the product can be split into

Drugs Therapy
Biological Therapy
Meditation
Physiotherapy
Other

Market segment by Application, split into

Under 25 Years Old
25-45 Years Old
Above 45 Years Old

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players.
To present the Major Depressive Disorder development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Major Depressive Disorder are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.